Wells Fargo’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$779K Sell
19,103
-6,670
-26% -$272K ﹤0.01% 3924
2026
Q2
$1.08M Buy
25,773
+8,287
+47% +$321K ﹤0.01% 4056
2026
Q1
$659K Sell
17,486
-7,189
-29% -$235K ﹤0.01% 3991
2025
Q4
$742K Buy
24,675
+12,670
+106% +$359K ﹤0.01% 4185
2025
Q3
$315K Buy
12,005
+5,414
+82% +$129K ﹤0.01% 4644
2025
Q2
$140K Sell
6,591
-349
-5% -$7.88K ﹤0.01% 4978
2025
Q1
$148K Buy
6,940
+225
+3% +$4.62K ﹤0.01% 4879
2024
Q4
$136K Buy
6,715
+5,235
+354% +$108K ﹤0.01% 5025
2024
Q3
$24.9K Buy
+1,480
New +$24.9K ﹤0.01% 5576

Other funds holding GRDN

Wells Fargo's GRDN Position: Q3 2026 in Review

Wells Fargo reduced its Guardian Pharmacy Services (GRDN) stake by 26% in Q3 2026, selling an estimated $272K and leaving 19,103 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.

Wells Fargo first reported a position in GRDN in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.08M in Q2 2026. 197 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.

  • Wells Fargo held 19,103 shares of Guardian Pharmacy Services worth $779K as of Q3 2026.
  • Wells Fargo sold 6,670 Guardian Pharmacy Services shares in Q3 2026, an estimated $272K.
  • Guardian Pharmacy Services made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #3924 holding.
  • Wells Fargo first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 9 quarters since.
  • Wells Fargo's Guardian Pharmacy Services position peaked at $1.08M in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.